Delivery Order SPE2DB22D1017-SPE2DB24FF7AM
Award Date 5/2/24
Potential Completion Date 5/3/24
Potential Value $2.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a major defense agency under the U.S. Department of Defense (DoD). The contract, valued at $2,059.51, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on a Firm Fixed Price basis. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of epinephrine 0.3 mg auto-injector devices to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, with a ceiling value of $2,981.82, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the performance period extends through October 2024. No set-aside designation was used for this...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,794.36 contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of 4,564,260 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,990.60 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for up to $999,999,999.00 through December...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, valued at $2,242.95, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price and is a delivery order with a completion date of May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $1,347.39, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00. The IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors, valued at $1,856.40. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency. The $3,087.98 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025, with a completion date of July 18, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,676.96 and an ultimate completion date of October 24, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF7AMDelivery Order
This federal contract award is for the supply of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corporation's Corporate Office division. The contract has a ceiling value of $2,373.36 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current contract award does not have a set-aside designation.
Generated 8/1/24, 9:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/2/24 |